SLC2A2 and hepatocellular carcinoma: Subgroup analysis of DFS showed that upregulation of SLC2A2 (HR = 3.26, 95% CI 1.58–6.73, P = 0.001) and PKM (HR = 1.81, 95% CI 1.46–2.24, P < 0.001) was associated with poor prognosis in HCC.